These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 8548414)
1. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine. Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414 [TBL] [Abstract][Full Text] [Related]
2. Elevated concentrations of plasma lipids and apolipoproteins B, C-III, and E are associated with the progression of coronary artery disease in familial hypercholesterolemic swine. Hasler-Rapacz J; Prescott MF; Von Linden-Reed J; Rapacz JM; Hu Z; Rapacz J Arterioscler Thromb Vasc Biol; 1995 May; 15(5):583-92. PubMed ID: 7749872 [TBL] [Abstract][Full Text] [Related]
3. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
4. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin. Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940 [TBL] [Abstract][Full Text] [Related]
5. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia. Bredie SJ; Westerveld HT; Knipscheer HC; de Bruin TW; Kastelein JJ; Stalenhoef AF Neth J Med; 1996 Aug; 49(2):59-67. PubMed ID: 8824106 [TBL] [Abstract][Full Text] [Related]
8. Effect of simvastatin on the lipid profile of hemodialysis patients. Nishikawa O; Mune M; Miyano M; Nishide T; Nishide I; Maeda A; Kimura K; Takahashi T; Kishino M; Tone Y; Otani H; Ogawa A; Maeda T; Yukawa S Kidney Int Suppl; 1999 Jul; 71():S219-21. PubMed ID: 10412781 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733 [TBL] [Abstract][Full Text] [Related]
10. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia. Schonfeld G; Aguilar-Salina C; Elias N Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813 [TBL] [Abstract][Full Text] [Related]
11. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia. Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788 [TBL] [Abstract][Full Text] [Related]
12. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548 [TBL] [Abstract][Full Text] [Related]
13. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863 [TBL] [Abstract][Full Text] [Related]
14. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482 [TBL] [Abstract][Full Text] [Related]
15. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. Nanjee MN; Cooke CJ; Olszewski WL; Miller NE J Lipid Res; 2000 Aug; 41(8):1317-27. PubMed ID: 10946020 [TBL] [Abstract][Full Text] [Related]
16. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia. Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197 [TBL] [Abstract][Full Text] [Related]
17. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia. Tomlinson B; Mak TW; Tsui JY; Woo J; Shek CC; Critchley JA; Masarei JR Am J Cardiol; 1995 Jul; 76(2):136A-139A. PubMed ID: 7604789 [TBL] [Abstract][Full Text] [Related]
18. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Attman PO; Alaupovic P Nephron; 1991; 57(4):401-10. PubMed ID: 2046821 [TBL] [Abstract][Full Text] [Related]
19. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160 [TBL] [Abstract][Full Text] [Related]
20. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels. Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]